AI assistant
PVP Ventures Ltd — Capital/Financing Update 2025
May 5, 2025
61131_rns_2025-05-05_d40acb87-1982-4d7b-b7fa-07f49d1460e7.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
05[th] May, 2025
==> picture [414 x 47] intentionally omitted <==
BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Kala Ghoda, Fort, Mumbai – 400001 Equity - Scrip Code: 517556
National Stock Exchange Limited “Exchange Plaza, Bandra Kurla Complex, Bandra (E) Mumbai – 400051 Equity-Symbol: PVP
Debt- 18PVL29A, 18PVL29
Subject: Intimation under Regulation 30 & 51 of SEBI (Listing Obligations and “ ” Disclosures Requirements) Regulations, 2015 ( Listing Regulations ) – Acquisition of Optimus Oncology Private Limited
This update is in continuation to our earlier communication dated 23[rd] April 2025, with respect to acquisition of Optimus Oncology Private Limited.
We wish to inform you that, today the Company has acquired 46,70,761 Equity Shares in Optimus Oncology Private Limited by paying the total consideration amount of Rs.54,73,66,481/- (Rupees Fifty Four Crores Seventy Three Lakhs Sixty Six Thousand Four Hundred and Eighty One Only).
By virtue of acquiring a substantial stake in Optimus Oncology Private Limited, the Company Optimus Oncology Private Limited becomes the subsidiary of PVP Ventures Limited with effect from today i.e. 05[th] May 2025.
Request you to kindly take the same on record.
Thanking You,
For PVP Ventures Limited
PRASAD VEERA Digitally signed by PRASAD VEERA POTLURI POTLURI Date: 2025.05.05 17:51:41 +05'30' Prasad V Potluri Chairman & Managing Director
==> picture [425 x 96] intentionally omitted <==